~~<i id='374864D850'><strike id='374864D850'><tt id='374864D850'><pre id='374864D850'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：explore 2025-09-30 18:20:54 - browse：249

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Food makers to regulators: Ultra

focus

leisure time

knowledge

explore

2:36Anemptyconferenceroomisseeninthisundatedstockphoto.Pgiam/STOCKPHOTO/GettyImagesYearsafterthedeat

WSS

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

How corporate America is slashing DEI workers amid backlash to diversity programs

Acelyrin, a rare IPO success, stumbles in its first big test

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Sen. Bill Cassidy on how to lower drug prices

Pig kidney works a record two months in donated body

explore

knowledge

focus

Medicare details structure of new drug price negotiation program

North Korean leader's powerful sister says warplanes repelled US spy plane

Medicare details structure of new drug price negotiation program

How redistricting in 6 states could affect who controls Congress

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

WATCH: Why do bright lights make us see spots?

Apple is now the first public company to be valued at $3 trillion

PEPFAR is under serious threat — and so is global health

Moonlake's readout produced a cash windfall. Risks remain

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

focus

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

FDA approves updated Covid vaccines

A common UTI test for kids haunts adults as a traumatic 'nightmare'

How redistricting in 6 states could affect who controls Congress

FDA approves Leqembi, a milestone in Alzheimer’s treatment

leisure time

knowledge

explore

explore